UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

Developmental changes in chest wall compliance in infancy and early childhood

Journal of applied physiology (1985), 1995-01, Vol.78 (1), p.179-184

1995

Volltextzugriff (PDF)

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134-1140

2008

Volltextzugriff (PDF)

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-04, Vol.6 (4), p.255-266

2000

Volltextzugriff (PDF)

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

The Lancet (British edition), 2005-08, Vol.366 (9485), p.579-582

2005

Volltextzugriff (PDF)

Bronchiolitis in infants

Current opinion in pediatrics, 2001-06, Vol.13 (3), p.256-260

Panitch, H B

2001

Volltextzugriff (PDF)

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Annals of neurology, 2013-03, Vol.73 (3), p.327-340

2013

Volltextzugriff (PDF)

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Volltextzugriff (PDF)

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Multiple sclerosis, 1995-11, Vol.1 (3), p.165-169

1995

Volltextzugriff (PDF)

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Lancet neurology, 2008-10, Vol.7 (10), p.903-914

2008

Volltextzugriff (PDF)

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Outcomes In Neonates With Bronchopulmonary Dysplasia And Tracheobronchomalacia

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

B52 NEONATAL LUNG DISEASE: FROM BENCH TO BABIES: Bethanechol Improves Respiratory Symptoms In Young Children With Tracheomalacia

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Neurology, 1996-12, Vol.47 (6), p.1457-1462

1996

Volltextzugriff (PDF)

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Airway Reactivity In Preterm Infants Is Associated With Increased Respiratory Morbidity In The First Year Of Life

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Multiple sclerosis, 2015-09, Vol.21 (10), p.1322-1331

2015

Volltextzugriff (PDF)

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

Neurology, 1987-07, Vol.37 (7), p.1097-1097

1987

Volltextzugriff (PDF)

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Nature medicine, 2000-10, Vol.6 (10), p.1176-1182

2000

Volltextzugriff (PDF)

The effect of interferon-β on mouse neural progenitor cell survival and differentiation

Biochemical and biophysical research communications, 2009-10, Vol.388 (2), p.181-186

2009

Volltextzugriff (PDF)

Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response

Journal of neuroimmunology, 2007-04, Vol.185 (1), p.168-174

2007

Volltextzugriff (PDF)

Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial

Journal of the neurological sciences, 2005-12, Vol.239 (1), p.67-74

2005

Volltextzugriff (PDF)

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study

Human brain mapping, 2015-10, Vol.36 (10), p.3749-3760

2015

Volltextzugriff (PDF)

Early treatment trials with interferon beta in multiple sclerosis

Multiple sclerosis, 1995, Vol.1 Suppl 1, p.S17-S21

Panitch, H S

1995

Volltextzugriff (PDF)

Epithelial modulation of preterm airway smooth muscle contraction

Journal of applied physiology (1985), 1993-03, Vol.74 (3), p.1437-1443

1993

Volltextzugriff (PDF)

Maturational changes in airway smooth muscle structure-function relationships

Pediatric research, 1992-02, Vol.31 (2), p.151-156

1992

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(95)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Developmental changes in chest wall compliance in infancy and early childhood

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

Bronchiolitis in infants

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Outcomes In Neonates With Bronchopulmonary Dysplasia And Tracheobronchomalacia

B52 NEONATAL LUNG DISEASE: FROM BENCH TO BABIES: Bethanechol Improves Respiratory Symptoms In Young Children With Tracheomalacia

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Airway Reactivity In Preterm Infants Is Associated With Increased Respiratory Morbidity In The First Year Of Life

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

The effect of interferon-β on mouse neural progenitor cell survival and differentiation

Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response

Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study

Early treatment trials with interferon beta in multiple sclerosis

Epithelial modulation of preterm airway smooth muscle contraction

Maturational changes in airway smooth muscle structure-function relationships

Aktive Filter

Suchergebnisse filtern